Author: A willow tree in the eternal blue sky

Zhao Chetou sneered in his heart. He didn't say anything about "technical industry and trade" and "trade, industry and technology". He imagined that what he was doing now was not financial investment, virtual industry, or making a lot of money!

After all, if you are engaged in industry, you will no longer be able to do it when you get older, but if you are engaged in investment...

Just ask for clear thinking. Instead, the experience and perspective accumulated over the years and through many cycles will become stronger and stronger with age.

Therefore, the so-called crown prince does not pay attention to seeking at all.

Zhiliu just asked for a puppet to stand there and move the ballast stone of industry to the east for steady development, allowing him to devote more of his energy to the capital field.

Is that one of the two main reasons for Guo Wei's previous defeat?

And words like, 'The position is not fixed, the executive committee failed to evaluate the five marshals every five years, but the good ones are mediocre ones', is pure deception.

Zhao Chetou said, whoever eats that kind of cake will be stupid.

Unlike Guo Wei, who is too shrewd, he also supports Yang Zhiyuan's stay in Taiwan.

Anyway, he has no chance to be on stage. From the beginning, he has regarded fantasy as a platform to make money. Therefore, it is most beneficial for a pig to walk in that position.

He just had to respond to Zhiliu and that would be the end of it.

If not Guo Wei...

Then there is no good fruit to eat.

Guo Wei, who has a strong feeling for the national industry, wants to truly take power and imagines that he will be moved back to the industrial path. He is a fool as an investor.

Therefore, Zhao Chetou did not mind clarifying Yang Zhiyuan’s doubts, “Mr. Yang, it’s not that simple, and generic drugs also require certain technical investment.

For example, in order to fully release the drug effect outside the human body, in addition to the disclosed active ingredients, a series of technical problems such as its formula, component ratio, etc. must be studied for imitation sustained-release preparations, which are not readily available.

, so there is no need for R&D investment.

However, the investment is much less than that required for innovative drugs. It may be reduced by one digit and then cut into the ankle, which is about 10 million to 20 million US dollars.

But unfortunately, most of the current pharmaceutical companies in their country are not even willing to pay that money.

After all, serious illness means that it is actually a niche group, and it is not as profitable as ordinary cold medicines.

Moreover, the risks are also great. If you are seriously ill and need your life, if the medicine does not work, you will be held accountable.

As for minor illnesses and chronic diseases, the medicines are easy to use and don't matter. They are safe, effective and highly profitable, so everyone is willing to produce them.

The entire foreign pharmaceutical industry, except for a few exceptions, is not like that."

Yang Zhiyuan frowned, "Old Zhao, he really didn't understand Ming Hong. What I told the teacher tomorrow will subvert his understanding."

He also knew that Zhiliu was making up lessons for him. If you know something, you know it. If you don't know it, you don't know it. There is no shame in it. If you don't understand it, just understand it.

Zhao Chetou laughed and said, "It's okay, Mr. Yang, just ask."

Yang Zhiyuan pressed his legs against his nose and rubbed his face for a moment, then asked seriously,

"In his opinion, Asan has also taken the path of generic drugs. Why can their generic drugs be of high quality and low price? It can basically be said that they are world-renowned.

He has a classmate whose elderly family member has gastric cancer, and he eats generic medicines from Asan, which are a few digits cheaper than imported medicines from abroad.

He wants to ask, why can't they do it? Asan's industry is far behind them."

Zhao Chetou nodded, "Mr. Yang, is it caused by two reasons?

First, whether it is a patent or whether it is a national act, it is difficult to say. He can say whether it is one of the tickets to embrace the world.

In fact, they were not a strong country in generic drugs until the 1970s. At that time, state power was promoting generics. Penicillin, for example, is very inconspicuous now, but it was a luxury product at the time. Their country directly sold the drug to the price of red cabbage.

One penny each.

All the low-priced drugs currently on the market are actually inconsistent with the unified behavior carried out by the country in those days.

After embracing the world, the country can no longer do that. If we want to respect intellectual property rights, companies can do it, but not their companies... haha."

Zhao Chetou sneered and continued, "Second, if it's a problem at the industrial stage, that's also why their companies are unwilling to make high-end generic drugs.

In fact, Asan's pharmaceuticals are completely dependent on them. In the pharmaceutical industry chain, Asan has a large demand for APIs and even many varieties of them are imported from them.

Is this driven by cost factors? Their APIs are too cheap compared to other countries around the world. If Asan makes them himself, firstly, he cannot make them, and secondly, even if he makes them, the cost would be several times that of theirs.

In layman's terms, the industry of APIs refers to the production of APIs from chemical and biological raw materials through synthesis, fermentation, purification, etc., which constitute the basic substances for pharmacological effects. After processing, they are delivered to Dongyou's finished drug manufacturing process.

.

Obviously, the competitiveness of the API industry depends on chemical industry and biology. And their country has an overwhelming advantage over the world in those two aspects.

For example, the chemical industry has an annual output value of one trillion U.S. dollars, accounting for one-third of the global market share, and is involved in all chemical product segments.

As for Asan, the total chemical output value is less than 10 billion US dollars a year, which is not even a fraction of theirs, and the technical capabilities are also very different.

In the biological field, their advantages are even more obvious. They take heparin as an example. It is a major medical discovery alongside insulin and is widely used in the preparation of cardiovascular drugs, and pig small intestine is the most sought-after purification source of heparin.

Therefore, the production of heparin is directly related to the scale of pig breeding.

Their country's pig breeding scale accounts for half of the world's total. Asan's industrial territory does not have that area at all, and their religious beliefs and customs do not accept pig raising.

Because of such a basic capability advantage, not only Ah San, but also the entire world has become dependent on them for their APIs. They can be said to be the core hub of APIs.

Well, that has also brought about a problem. Their finished drug industry has enjoyed that dividend because of the policy. Their production costs are too low. The market for low-end generic drugs is huge. Even if penicillin costs a penny a pill, their gross profit

They can all reach 80% or above, so they have no incentive to make high-end generic drugs.

On the contrary, Asan is stuck by them because of its raw material drugs. No matter how it makes low-end drugs, it can't lower its price than theirs. It can only make profits by making high-end generic drugs."

Yang Zhiyuan nodded in realization, that was so ironic.

In an instant, Yang Zhiyuan froze there.

He swallowed hard and said, "Old Zhao, are all the companies we invested in... good?"

Hearing this, Zhao Chetou nodded with a wry smile, "Most of them do not. Small factories, their valuations were relatively low when they entered, and they have huge room for imagination in the capital market."

Zhiliu continued angrily, "Then that's why he and Xiao Zhao are so angry.

That bastard Qin Tianchuan! As soon as he made a move, he directly brought the bottom of the entire foreign pharmaceutical industry to the bottom.

If we seek drug consistency, we must ensure that the efficacy of generic drugs is the same as that of the original drugs, which can directly destroy at least 80% of pharmaceutical companies outside the industry."

There was something Zhiliu didn't say.

But the entire industry combined couldn't do anything against Qin Tianchuan.

The pharmaceutical sector accounts for a very small proportion in Magnolia officinalis, and what they do is proprietary Chinese medicine.

An industry that purely sells counterfeit medicines, even if they join together, cannot compete with the big guys in the "national" industry like Qin Tianchuan.

After all, would the country not know the quality of those pharmaceutical industries?

At this moment, Zhi Liufu was both shocked and frightened, because Hony Capital had invested in a large number of such pharmaceutical companies, spending billions of real gold and silver.

But unfortunately, in addition to the money obtained from capital market financing, there is also a certain scale of bank credit among the billions.

It doesn't matter. For entrepreneurs, the money they borrow based on their ability is their own money.

Just hope that the ballast stone of the industrial sector can bring stable cash flow. Even if you lose everything, it will not shake the foundation of your dream. It will only mean tightening your belt and tightening your confinement for a few years.

But no, Hony Capital’s investment is not a self-operated direct investment, but is carried out through funds raising social capital.

Although there is no prioritization of public shares and real debt investment methods, the big bosses behind the investment represented by the social capital obviously cannot accept the fact that the principal cannot be recovered.

To be honest, if Qin Tianchuan did what he did, Zhiliu could be thrown into the sea.

At that time, they will ask me whether I am the "godfather of business", and it is only natural that "it is a lot of hard-earned money".

When Yang Zhiyuan learned the full picture of that plate, he suddenly became sweaty.

Compared to Guo Wei, he is a pig.

But compared to ordinary people, he doesn't have the big canopy that doesn't leave half of his lovesickness on the road.

In a flash of lightning, Yang Zhiyuan understood the current situation.

"Teacher, the coordination meeting is here, and except for the drug administration, all departments have expressed their agreement.

Whether the reasons proposed by the Food and Drug Administration required a certain buffer time for pharmaceutical companies, the leader did not express his position on the spot and asked, "Three years is enough."

"Bu Nao, the leaders at the meeting verbally requested Hopu Group to take the lead and come up with a practical plan, and we will discuss it next time."

Yang Zhiyuan finally understood why such things must be done by enterprises.

In the final analysis, the country does not seek to save face through imitation.

Zhiliu and Zhao Chetou were relieved when they heard this.

The worst-case scenario is whether Hopu's proposal is discussed and approved. There is still a buffer time of about three years and a lot of room for maneuver. At the worst, we will spend money to improve the quality and pass the consistency evaluation.

Of course, the best thing is that everyone thinks that this matter needs to be prudent and prudent, and the whole thing will be delayed for ten or eight years.

After all, the existence of things has its rationality. At this time, the pharmaceutical companies are too weak, and it would not be wrong to kill the entire industry with one thing.

At that time, Zhiliu's message rang twice, and the mailbox prompt sounded. He opened it and looked at it, then stood up and walked to the computer.

After a while, as the roar of the printer disappeared, he came back with three documents.

Zhao Chetou and Yang Zhiyuan took a look at it to see if it was the minutes of tomorrow's meeting.
To be continued...